TCR2 Therapeutics Inc (NASDAQ:TCRR)
| 1.75 BATS BZX Real-Time Price As of 1:40pm ET |  -0.03 / -1.69%Today’s Change | 1.69 Today|||52-Week Range 9.08 | -62.45% Year-to-Date |
Latest TCRR News | Press Releases
No recent news for TCR2 Therapeutics Inc.
Today’s Trading
| Previous close | 1.78 |
| Today’s open | 1.79 |
| Day’s range | 1.74 - 1.86 |
| Volume | 9,372 |
| Average volume (3 months) | 359,413 |
| Market cap | $82.6M |
Data as of 1:40pm ET, 09/29/2022
Growth & Valuation
| Earnings growth (last year) | -9.71% |
| Earnings growth (this year) | -18.88% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GNPXGenprex Inc | +0.03 | +2.07% |
| ---- | ||
| EYENEyenovia Inc | -0.12 | -5.80% |
| CRDLCardiol Therapeutics... | -0.09 | -8.41% |
Data as of 1:48pm ET, 09/29/2022
Financials
| Next reporting date | November 16, 2022 |
| EPS forecast (this quarter) | -$0.83 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$99.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
